Verastem, Inc. (VSTM) Social Stream
Verastem Inc (VSTM) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering VSTM.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
VSTM's average price target has moved up $2.37 over the prior 12 months.
VSTM reports an average of 148.39% for its upside potential over the past 48 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
VSTM Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
VSTM's average broker recommendation rating improved by 1.33 over the prior 48 weeks.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for VSTM as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, Verastem Inc's average analyst price target is higher than 12.7% of them.
- In terms of how Verastem Inc fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 278.85% of that group.
- In the context of Pharmaceutical Products stocks, Verastem Inc's number of analysts covering the stock is higher than 82.97% of them.
- To contextualize these metrics, consider that out of stocks in the small market cap category, Verastem Inc's variance in analysts' estimates is lower than -95.33% of them.
Make investment decisions regarding VSTM using the data that counts. Try POWR Ratings for free.